{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:49:19Z","timestamp":1760730559976},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T00:00:00Z","timestamp":1385337600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The hereditary hemorrhagic telangiectasia syndrome (HHT), also known as the Rendu\u2013Osler-Weber syndrome is a multiorganic vascular disorder inherited as an autosomal dominant trait. Diagnostic clinical criteria include: epistaxis, telangiectases in mucocutaneous and gastrointestinal sites, arteriovenous malformations (AVMs) most commonly found in pulmonary, hepatic and cerebral circulations, and familial inheritance. HHT is transmitted in 90% of the cases as an autosomal dominant condition due to mutations in either endoglin (<jats:italic>ENG<\/jats:italic>), or activin receptor-like kinase 1 (ACVRL1\/ALK1) genes (HHT type 1 and 2, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We have carried out a genetic analysis of four independent Spanish families with HHT clinical criteria, which has permitted the identification of new large deletions in ENG. These mutations were first detected using the MLPA technique and subsequently, the deletion breakpoints were mapped using a customized copy number variation (CNV) microarray. The array was designed to cover the ENG gene and surrounding areas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All tested families carried large deletions ranging from 3-kb to 100-kb, involving the <jats:italic>ENG<\/jats:italic> gene promoter, several ENG exons, and the two downstream genes FGSH and CDK9. Interestingly, common breakpoints coincident with Alu repetitive sequences were found among these families.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The systematic hybridization of DNA from HHT families, with deletions or duplications, to custom designed microarrays, could allow the mapping of breakpoints, coincident with repetitive Alu sequences that might act as \u201chot spots\u201d in the development of chromosomal anomalies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-14-121","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T08:01:09Z","timestamp":1385366469000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1"],"prefix":"10.1186","volume":"14","author":[{"given":"Ana","family":"Fontalba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L","family":"Fern\u00e1ndez-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Zarrabeitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Recio-Poveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Albi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L","family":"Ojeda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Bernab\u00e9u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa M","family":"Botella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,25]]},"reference":[{"key":"1148_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJM199510053331407","volume":"333","author":"AE Guttmacher","year":"1995","unstructured":"Guttmacher AE, Marchuk DA, White RI: Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995, 333: 918-924. 10.1056\/NEJM199510053331407.","journal-title":"N Engl J Med"},{"key":"1148_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000, 91: 66-67. 10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P.","journal-title":"Am J Med Genet"},{"key":"1148_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","volume":"2","author":"CL Shovlin","year":"2010","unstructured":"Shovlin CL: Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 2: 203-219.","journal-title":"Blood Rev"},{"key":"1148_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/humu.10026","volume":"19","author":"M Dakeishi","year":"2002","unstructured":"Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A: Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mut. 2002, 19: 140-148. 10.1002\/humu.10026.","journal-title":"Hum Mut"},{"key":"1148_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/157016110791330771","volume":"8","author":"R Zarrabeitia","year":"2010","unstructured":"Zarrabeitia R, Albi\u00f1ana V, Salcedo M, Se\u00f1aris-Gonzalez B, Fernandez-Forcelledo JL, Botella LM: A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Curr Vasc Pharmacol. 2010, 8: 473-481. 10.2174\/157016110791330771.","journal-title":"Curr Vasc Pharmacol"},{"key":"1148_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL: Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009, 17: 860-871. 10.1038\/ejhg.2009.35.","journal-title":"Eur J Hum Genet"},{"key":"1148_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al: ENG, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994, 8: 345-351. 10.1038\/ng1294-345.","journal-title":"Nat Genet"},{"key":"1148_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/gr.5.1.21","volume":"5","author":"DW Johnson","year":"1995","unstructured":"Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, Jackson CE, Porteous ME, Marchuk DA: A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res. 1995, 5: 21-28. 10.1101\/gr.5.1.21.","journal-title":"Genome Res"},{"key":"1148_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ajmg.a.33206","volume":"152","author":"C Gallione","year":"2010","unstructured":"Gallione C, Aylsworth AS, Beis J, Berk T, Bernhardt B, Clark RD, Clericuzio C, Danesino C, Drautz J, Fahl J, Fan Z, Faughnan ME, et al: Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. Am J Med Genet A. 2010, 152: 333-339.","journal-title":"Am J Med Genet A"},{"key":"1148_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/humu.9413","volume":"27","author":"A Fernandez-L","year":"2006b","unstructured":"Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, Ramirez JR, Coto E, Lenato GM, Bernabeu C, Botella LM: Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of ENG and ALK1. Hum Mutat. 2006b, 27: 295-","journal-title":"Hum Mutat"},{"key":"1148_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jmg.2004.028712","volume":"42","author":"SG Cole","year":"2005","unstructured":"Cole SG, Begbie ME, Wallace GMF, Shovlin CL: A new locus for hereditary haemorrhagic telangiactasia (HHT3) maps to chromosome 5. J Med Genet. 2005, 42: 577-582. 10.1136\/jmg.2004.028712.","journal-title":"J Med Genet"},{"key":"1148_CR12","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/ajmg.a.31450","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R: A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet. 2006, 140: 2155-2162.","journal-title":"Am J Med Genet"},{"key":"1148_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/CS20110086","volume":"121","author":"JF Santiba\u00f1ez","year":"2011","unstructured":"Santiba\u00f1ez JF, Quintanilla M, Bernabeu C: TGF-\u03b2\/TGF-\u03b2 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2011, 121: 233-251. 10.1042\/CS20110086.","journal-title":"Clin Sci (Lond)"},{"key":"1148_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke P, Arthur H: Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 2007, 8: 857-869.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1148_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","volume":"21","author":"MJ Goumans","year":"2002","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P: Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002, 21: 1743-1753. 10.1093\/emboj\/21.7.1743.","journal-title":"EMBO J"},{"key":"1148_CR16","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","volume":"23","author":"F Lebrin","year":"2004","unstructured":"Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P: Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction. EMBO J. 2004, 23: 4018-4028. 10.1038\/sj.emboj.7600386.","journal-title":"EMBO J"},{"key":"1148_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/jcp.20311","volume":"204","author":"FJ Blanco","year":"2005","unstructured":"Blanco FJ, Santibanez JF, Guerrro-Esteo M, Langa C, Vary CP, Bernabeu C: Interactions and functional interplay between Endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol. 2005, 204: 574-584. 10.1002\/jcp.20311.","journal-title":"J Cell Physiol"},{"key":"1148_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3121\/cmr.4.1.66","volume":"4","author":"A Fern\u00e1ndez-L","year":"2006a","unstructured":"Fern\u00e1ndez-L A, Sanz-Rodriguez F, Blanco FJ, Bernab\u00e9u C, Botella LM: Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res. 2006a, 4: 66-78. 10.3121\/cmr.4.1.66.","journal-title":"Clin Med Res"},{"key":"1148_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","volume":"20","author":"E Pardali","year":"2010","unstructured":"Pardali E, Goumans MJ, Ten Dijke P: Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 2010, 20: 556-567. 10.1016\/j.tcb.2010.06.006.","journal-title":"Trends Cell Biol"},{"key":"1148_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1750-1172-6-85","volume":"6","author":"K Damjanovich","year":"2011","unstructured":"Damjanovich K, Langa C, Blanco FJ, McDonald J, Botella LM, Bernabeu C, Wooderchak-Donahue W, Stevenson DA, Bayrak-Toydemir P: 5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2011, 6: 85-10.1186\/1750-1172-6-85.","journal-title":"Orphanet J Rare Dis"},{"key":"1148_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2350-12-130","volume":"12","author":"MJ Kim","year":"2011","unstructured":"Kim MJ, Kim ST, Lee HD, Lee KY, Seo J, Lee JB, Lee YJ, Oh SP: Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia. BMC Med Genet. 2011, 12: 130-10.1186\/1471-2350-12-130.","journal-title":"BMC Med Genet"},{"key":"1148_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2350-9-75","volume":"9","author":"A Fontalba","year":"2008","unstructured":"Fontalba A, Fernandez-L A, Garc\u00eda-Alegria E, Albi\u00f1ana V, Garrido-Martin EM, Blanco FJ, Zarrabeitia R, Perez-Molino A, Bernabeu-Herrero ME, Ojeda ML, Fernandez-Luna JL, Bernabeu C, Botella LM: Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia. BMC Med Genet. 2008, 9: 75-10.1186\/1471-2350-9-75.","journal-title":"BMC Med Genet"},{"key":"1148_CR23","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30: e57-10.1093\/nar\/gnf056.","journal-title":"Nucleic Acids Res"},{"key":"1148_CR24","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V92.12.4677","volume":"92","author":"C R\u00edus","year":"1998","unstructured":"R\u00edus C, Smith JD, Almendro N, Langa C, Botella LM, Marchuk DA, Vary CP, Bernab\u00e9u C: Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood. 1998, 92: 4677-4690.","journal-title":"Blood"},{"key":"1148_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00439-010-0825-4","volume":"128","author":"J Richards-Yutz","year":"2010","unstructured":"Richards-Yutz J, Grant K, Chao EC, Walther SE, Ganguly A: Update on molecular diagnosis of hereditary hemorrhagic telangiectasia. Hum Genet. 2010, 128: 61-77. 10.1007\/s00439-010-0825-4.","journal-title":"Hum Genet"},{"key":"1148_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jmg.2006.042606","volume":"43","author":"NL Prigoda","year":"2006","unstructured":"Prigoda NL, Savas S, Abdalla SA, Piovesan B, Rushlow D, Vandezande K, Zhang E, Ozcelik H, Gallie BL, Letarte M: Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet. 2006, 43: 722-728. 10.1136\/jmg.2006.042606.","journal-title":"J Med Genet"},{"key":"1148_CR27","doi-asserted-by":"publisher","first-page":"34486","DOI":"10.1074\/jbc.M011611200","volume":"14","author":"LM Botella","year":"2001","unstructured":"Botella LM, S\u00e1nchez-Elsner T, Rius C, Corb\u00ed A, Bernab\u00e9u C: Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation. J Biol Chem. 2001, 14: 34486-34494.","journal-title":"J Biol Chem"},{"key":"1148_CR28","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1182\/blood.V100.12.4001","volume":"100","author":"LM Botella","year":"2002","unstructured":"Botella LM, S\u00e1nchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CP, Ramirez JR, Friedman S, Bernab\u00e9u C: Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood. 2002, 100: 4001-4010. 10.1182\/blood.V100.12.4001.","journal-title":"Blood"},{"key":"1148_CR29","doi-asserted-by":"publisher","first-page":"43799","DOI":"10.1074\/jbc.M207160200","volume":"277","author":"T S\u00e1nchez-Elsner","year":"2002","unstructured":"S\u00e1nchez-Elsner T, Botella LM, Velasco B, Langa C, Bernab\u00e9u C: Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem. 2002, 277: 43799-43808. 10.1074\/jbc.M207160200.","journal-title":"J Biol Chem"},{"key":"1148_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1399-0004.2010.01418.x","volume":"78","author":"W Wooderchak","year":"2010","unstructured":"Wooderchak W, Gedge F, McDonald M, Krautscheid P, Wang X, Malkiewicz J, Bukjiok CJ, Lewis T, Bayrak-Toydemir P: Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family. Clinical Genetics. 2010, 78: 484-489. 10.1111\/j.1399-0004.2010.01418.x.","journal-title":"Clinical Genetics"},{"key":"1148_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/mgme.1999.2864","volume":"67","author":"PL Deininger","year":"1999","unstructured":"Deininger PL, Batzer MA: Alu repeats and human disease. Mol Genet Metab. 1999, 67: 183-193. 10.1006\/mgme.1999.2864.","journal-title":"Mol Genet Metab"},{"key":"1148_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1086\/504600","volume":"79","author":"SK Sen","year":"2006","unstructured":"Sen SK, Han K, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA: Human genomic deletions mediated by recombination between Alu elements. Am J Human Genet. 2006, 79: 41-53. 10.1086\/504600.","journal-title":"Am J Human Genet"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-14-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-14-121\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-14-121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-14-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:13:39Z","timestamp":1630548819000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-14-121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1148"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-14-121","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,25]]},"assertion":[{"value":"2 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}